Leaflet ROMLA 25mg / 25mg / g cream


Indicated for: local anesthesia

Substance: lidocaine + prilocaine (local anesthetics)

ATC: N01BB20 (Nervous system | Anesthetics, local | Amides)

The combination of lidocaine and prilocaine is used for local anesthesia of the skin before medical procedures such as needle insertion or minor surgical interventions. Both substances are local anesthetics that reduce pain sensitivity.

The medication is applied topically, usually in the form of a cream, and should be left to act for 30-60 minutes before the procedure. It is important to follow the doctor's instructions for use.

Side effects may include redness, irritation, or a burning sensation at the application site. In rare cases, allergic reactions or methemoglobinemia may occur.

This combination is not recommended for patients with hypersensitivity to lidocaine, prilocaine, or other components of the product. It should also be used with caution in infants and patients with glucose-6-phosphate dehydrogenase deficiency.

General data about ROMLA 25mg / 25mg / g

  • Substance: lidocaine + prilocaine
  • Date of last drug list: 01-05-2021
  • Commercial code: W67556001
  • Concentration: 25mg / 25mg / g
  • Pharmaceutical form: cream
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: RAFARM SA - GRECIA
  • Holder: MAGNAPHARM MARKETING & SALES ROMANIA S.R.L. - ROMANIA
  • Number: 13998/2021/01
  • Shelf life: 3 years-dupa ambalarea pt. coemrcializare;after the first opening-it is used immediately

Pharmaceutical forms available for lidocaine + prilocaine

Concentrations available for lidocaine + prilocaine

  • 150mg/50mg/ml
  • 25mg/25mg/g